Improving antithrombotic management in patients with atrial fibrillation: current status and perspectives.
Despite overwhelming evidence of the benefits of risk-adjusted oral anticoagulation on stroke reduction in patients with atrial fibrillation (AF), there is still considerable undertreatment. A multidisciplinary expert group was formed to discuss issues surrounding anticoagulant treatment of patients...
Auteurs principaux: | Levi, M, Hobbs, F, Jacobson, A, Pisters, R, Prisco, D, Bernardo, A, Haas, M, Heidrich, J, Rosenberg, M, Nielsen, J, Wuillemin, W |
---|---|
Format: | Journal article |
Langue: | English |
Publié: |
2009
|
Documents similaires
-
Choosing antithrombotics for atrial fibrillation in primary care
par: Mustafa, M, et autres
Publié: (2020) -
ANTITHROMBOTIC THERAPY AT AN ATRIAL FIBRILLATION: OLD PROBLEMS AND NEW SOLUTIONS
par: M. Yu. Gilyarov, et autres
Publié: (2016-01-01) -
ANTITHROMBOTIC THERAPY IN ATRIAL FIBRILLATION: NEW DATA AND NEW HORIZONS
par: M. Yu. Gilyarov, et autres
Publié: (2016-01-01) -
ANTITHROMBOTIC THERAPY IN ATRIAL FIBRILLATION: NEW DATA AND NEW HORIZONS
par: M. Yu. Gilyarov, et autres
Publié: (2016-01-01) -
ANTITHROMBOTIC THERAPY IN NONVALVULAR ATRIAL FIBRILLATION: PROBLEMS AND PROSPECTS
par: A. Y. Rychkov, et autres
Publié: (2016-01-01)